151 related articles for article (PubMed ID: 28811235)
1. Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway.
Wu JL; Zou JY; Hu ED; Chen DZ; Chen L; Lu FB; Xu LM; Zheng MH; Li H; Huang Y; Jin XY; Gong YW; Lin Z; Wang XD; Zhao MF; Chen YP
Immunol Lett; 2017 Oct; 190():169-176. PubMed ID: 28811235
[TBL] [Abstract][Full Text] [Related]
2. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier.
Hu ED; Chen DZ; Wu JL; Lu FB; Chen L; Zheng MH; Li H; Huang Y; Li J; Jin XY; Gong YW; Lin Z; Wang XD; Xu LM; Chen YP
Cell Immunol; 2018 Jun; 328():24-32. PubMed ID: 29627063
[TBL] [Abstract][Full Text] [Related]
3. Novel syngeneic liver hapten protein compounds play different roles in pathogenesis of autoimmune hepatitis in the C57BL/6 mouse.
Wen-Ji C; Jin-Hui W; Shu-Bing W; Min Z; Jie C; Zhi-Xun L; Yu-Yuan L; Yu-Qiang N; Min-Hu C
Hepatogastroenterology; 2013 Sep; 60(126):1438-44. PubMed ID: 23933937
[TBL] [Abstract][Full Text] [Related]
4. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib attenuates depressive-like behavior associated with immunological liver injury in C57BL/6 mice through TNF-α and NF-κb dependent mechanisms.
ELnahas EM; Zeid MS; Kawy HS; Hendawy N; Baher W
Life Sci; 2016 Oct; 163():23-37. PubMed ID: 27580523
[TBL] [Abstract][Full Text] [Related]
6. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline attenuates cytokine stress and Fas system in syngeneic liver proteins induced experimental autoimmune hepatitis.
Hendawy N
Biomed Pharmacother; 2017 Aug; 92():316-323. PubMed ID: 28551553
[TBL] [Abstract][Full Text] [Related]
9. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
Cresci GA; Glueck B; McMullen MR; Xin W; Allende D; Nagy LE
J Gastroenterol Hepatol; 2017 Sep; 32(9):1587-1597. PubMed ID: 28087985
[TBL] [Abstract][Full Text] [Related]
11. Murine experimental autoimmune hepatitis: nonspecific inflammation due to adjuvant oil.
Howell CD; Yoder TD
Clin Immunol Immunopathol; 1994 Jul; 72(1):76-82. PubMed ID: 8020196
[TBL] [Abstract][Full Text] [Related]
12.
Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
Front Immunol; 2020; 11():569104. PubMed ID: 33123141
[TBL] [Abstract][Full Text] [Related]
13. Chlorogenic acid ameliorated concanavalin A-induced hepatitis by suppression of Toll-like receptor 4 signaling in mice.
Yuan Y; Gong X; Zhang L; Jiang R; Yang J; Wang B; Wan J
Int Immunopharmacol; 2017 Mar; 44():97-104. PubMed ID: 28088700
[TBL] [Abstract][Full Text] [Related]
14. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity.
Lohse AW; Manns M; Dienes HP; Meyer zum Büschenfelde KH; Cohen IR
Hepatology; 1990 Jan; 11(1):24-30. PubMed ID: 2271015
[TBL] [Abstract][Full Text] [Related]
16. Sodium Butyrate Reduces Organ Injuries in Mice with Severe Acute Pancreatitis Through Inhibiting HMGB1 Expression.
Zhang T; Xia M; Zhan Q; Zhou Q; Lu G; An F
Dig Dis Sci; 2015 Jul; 60(7):1991-9. PubMed ID: 25686746
[TBL] [Abstract][Full Text] [Related]
17. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
18. Remodeling gut microbiota by Clostridium butyricum (C.butyricum) attenuates intestinal injury in burned mice.
Zhang D; Zhu C; Fang Z; Zhang H; Yang J; Tao K; Hu D; Han J; Yang X
Burns; 2020 Sep; 46(6):1373-1380. PubMed ID: 32014349
[TBL] [Abstract][Full Text] [Related]
19. MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis.
Ojiro K; Ebinuma H; Nakamoto N; Wakabayashi K; Mikami Y; Ono Y; Po-Sung C; Usui S; Umeda R; Takaishi H; Yamagishi Y; Saito H; Kanai T; Hibi T
Biochem Biophys Res Commun; 2010 Sep; 399(4):744-9. PubMed ID: 20696131
[TBL] [Abstract][Full Text] [Related]
20. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway.
Yan H; Ajuwon KM
PLoS One; 2017; 12(6):e0179586. PubMed ID: 28654658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]